Role of microRNAs in obesity and obesity-related diseases

111Citations
Citations of this article
188Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In recent years, the link between regulatory microRNAs (miRNAs) and diseases has been the object of intensive research. miRNAs have emerged as key mediators of metabolic processes, playing crucial roles in maintaining/altering physiological processes, including energy balance and metabolic homeostasis. Altered miRNAs expression has been reported in association with obesity, both in animal and human studies. Dysregulation of miRNAs may affect the status and functions of different tissues and organs, including the adipose tissue, pancreas, liver, and muscle, possibly contributing to metabolic abnormalities associated with obesity and obesity-related diseases. More recently, the discovery of circulating miRNAs easily detectable in plasma and other body fluids has emphasized their potential as both endocrine signaling molecules and disease indicators. In this review, the status of current research on the role of miRNAs in obesity and related metabolic abnormalities is summarized and discussed.

Cite

CITATION STYLE

APA

Iacomino, G., & Siani, A. (2017, September 25). Role of microRNAs in obesity and obesity-related diseases. Genes and Nutrition. BioMed Central Ltd. https://doi.org/10.1186/s12263-017-0577-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free